A rationalization of the acidic pH dependence for stromelysin-1 (matrix metalloproteinase-3) catalysis and inhibition

Citation
Ll. Johnson et al., A rationalization of the acidic pH dependence for stromelysin-1 (matrix metalloproteinase-3) catalysis and inhibition, J BIOL CHEM, 275(15), 2000, pp. 11026-11033
Citations number
46
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
275
Issue
15
Year of publication
2000
Pages
11026 - 11033
Database
ISI
SICI code
0021-9258(20000414)275:15<11026:AROTAP>2.0.ZU;2-A
Abstract
The pH dependence of matrix metalloproteinase (MMP) catalysis is described by a broad bell-shaped curve, indicating the involvement of two unspecified ionizable groups in proteolysis, Stromelysin-1 has a third pK(a) near 6, r esulting in a uniquely sharp acidic catalytic optimum, which has recently b een attributed to His(224). This suggests the presence of a critical, but u nidentified, S1' substructure. Integrating biochemical characterizations of inhibitor-enzyme interactions with active site topography from correspondi ng crystal structures, we isolated contributions to the pH dependence of ca talysis and inhibition of active site residues Glu(202) and His(224). The a cidic pK(a) 5.6 is attributed to the Glu(202). zinc . H2O complex, consiste nt with a role for the invariant active site Glu as a general base in MMP c atalysis, The His(224)-dependent substructure is identified as a tripeptide (Pro(221)-Leu(222)-Tyr(223)) that forms the substrate cleft lower wall. Su bstrate binding induces a beta-conformation in this sequence, which extends and anchors the larger beta-sheet of the enzyme . substrate complex and ap pears to be essential for productive substrate binding. Because the PXY tri peptide is strictly conserved among MMPs, this "beta-anchor" may represent a common motif required for macromolecular substrate hydrolysis. The striki ng acidic profile of stromelysin-1 defined by the combined ionization of Gl u(202) and His(224) allows the design of highly selective inhibitors.